Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation in Japan

Hepatology Research

Volumn 37, Issue SUPPL. 3, 2007, Pages

  Yamagiwa, Satoshi ^a   Ichida, Takafumi ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

Living donor liver transplantation; Primary biliary cirrhosis; Primary sclerosing cholangitis; Recurrence

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MITOCHONDRION ANTIBODY; OKT 3; PYRUVATE DEHYDROGENASE COMPLEX; STEROID; TACROLIMUS; URSODEOXYCHOLIC ACID;

BILE DUCT OBSTRUCTION; CADAVER DONOR; CHOLANGIOGRAPHY; COLORECTAL CANCER; CONFERENCE PAPER; DRUG WITHDRAWAL; FOLLOW UP; GRAFT SURVIVAL; HEPATOBILIARY SYSTEM CANCER; HISTOPATHOLOGY; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; OVERALL SURVIVAL; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SURVIVAL RATE;

EID: 35348872504     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00250.x     Document Type: Conference Paper

References (23)

1. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database. Liver Transpl 2004; 10: 886-97.
2. The Japanese Liver Transplantation Society. Liver transplantation in Japan: Registry by the Japanese liver transplantation society. Jpn J Transpl 2005; 40: 518-26 (in Japanese with English abstract).
3. Neuberger J. Recurrent primary biliary cirrhosis. Liver Transpl 2003; 9: 539-46.
4. Neuberger JM, Portmann B, MacDougall B, Calne R, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982; 306: 1-4.
5. Hubscher S, Elias E, Buckels J, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18: 173-84.
6. Hashimoto E, Shimada M, Noguchi S et al. Disease recurrence after living liver transplantation for primary biliary cirrhosis: A clinical and histological follow-up study. Liver Transpl 2001; 7: 588-95.
7. Takeishi T, Sato Y, Ichida T, Yamamoto S, Kobayashi T, Hatakeyama K. Short-term outcomes of living-related liver transplantation for primary biliary cirrhosis and its recurrence: Report of five cases. Transplant Proc 2003; 35: 372.
8. Hasegawa K, Sugawara Y, Imamura H, Ikeda M, Kokudo N, Makuuchi M. Living donor liver transplantation for primary biliary cirrhosis: Retrospective analysis of 50 patients in a single center. Transpl Int 2005; 18: 794-9.
9. Morioka D, Egawa H, Kasahara M et al. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 80-90.
10. Abu-Elamgd K, Demetris J, Rakela J et al. Transplantation for primary biliary cirrhosis: Recurrence and outcome in 421 patients (Abstract). Hepatology 1997; 26: 176A.
11. Garcia R, Garcia C, McMaster P, Neuberger JM. Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center. Hepatology 2001; 33: 22-7.
12. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-73.
13. Van de Water J, Gerson LB, Ferrell LD et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 1996; 24: 1079-84.
14. Moritoki Y, Ueno Y, Kanno N et al. Lack of evidence that bone marrow cells contribute to cholangiocytes repopulation during experimental cholestatic ductal hyperplasia. Liver Int 2006; 26: 457-66.
15. Lerut J, Demetria AJ, Stieber AC et al. Intrahepatic bile duct strictures after human orthotopic liver transplantation. Transplant Int 1988; 1: 127-30.
16. Graziadei IW, Wiesner RH, Batts KP et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999; 29: 1050-6.
17. Graziadei IW. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2002; 8: 575-81.
18. Miki C, Harrison JD, Gunson BK, Buckels JAC, McMaster P, Mayer AD. Inflammatory bowel disease in primary sclerosing cholangitis: An analysis of patients undergoing liver transplantation. Br J Surg 1995; 82: 1114-17.
19. Vera A, Moledina S, Gunson B et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002; 360: 1943-4.
20. Khettry U, Keaveny A, Goldar-Najafi A et al. Liver transplantation for primary sclerosing cholangitis: A long-term clinicopathologic study. Hum Pathol 2003; 34: 1127-36.
21. Kugelmas M, Spiegelman P, Osgood MJ et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003; 9: 727-32.
22. Brandsaeter B, Schrumpf E, Bentdal O et al. Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005; 11: 1361-9.
23. LaRusso NF, Shneider BL, Black D et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006; 44: 746-64.